Amphastar Pharmaceuticals's total assets for Q4 2024 were $1.58B, an increase of 2.09% from the previous quarter. DE:29A total liabilities were $845.17M for the fiscal quarter, a 3.38% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.